News

What Is Progesterone API? Progesterone (CAS 57-83-0) is a naturally occurring steroid hormone and a foundational active pharmaceutical ingredient used in a wide range of gynecological, reproductive...

What Is SLU-PP-332 Powder? SLU-PP-332 is an experimental small molecule compound and a pan-ERR agonist that activates estrogen-related receptor alpha (ERRα), ERR beta (ERRβ), and ERR gam...

Introduction Demand for Fenbendazole API continues to rise steadily in 2026 as global livestock production scales up and veterinary pharmaceutical manufacturers ramp up procurement of high-quality ...

Key Takeaways Copper Peptide GHK-Cu is one of the fastest-growing cosmetic peptide ingredients entering 2026. Rising consumer interest in repair skincare and barrier support is accelerating market ...

Key Takeaways Melanotan II demand continues to rise due to expanding melanocortin receptor research and global peptide drug discovery investment. Cyclic peptide manufacturing remains constrained by...

Published: By HDM Biotech Technical R&D Team | Medically reviewed by Li Wei, M.S. in Pharmaceutical Engineering, 12+ years of peptide API synthesis & quality control experience

HDM BIO, a cGMP-compliant peptide API manufacturer based in China, today announced the official scale-up of its commercial tirzepatide API production line to meet surging global demand for research...

Global Demand for Peptide APIs Continues to AccelerateGlobal Demand for Peptide APIs Continues to Accelerate In 2026, global demand for peptide active pharmaceutical ingredients (APIs) is accelerat...

What is Peptide API Manufacturing? Peptide API manufacturing is a multi-step process involving solid-phase synthesis (SPPS), cleavage, purification via HPLC, and lyophilization. High-purity peptide...

Choosing a reliable peptide API supplier in China requires evaluating GMP compliance, purity standards, manufacturing capability, and long-term supply stability. For high-demand products like semag...

Driven by indication expansion and patent expirations across Canada, China, India, and Brazil, the global semaglutide market continues strong growth in 2026. The finished drug market is expected to...